2006 Other Outputs Small molecule glycosaminoglycan mimeticsBanwell, M. G., Bonnet, M., Ferro, V., Kreipl, A., Renner, J. and Offermann, D. A. (2006). Small molecule glycosaminoglycan mimetics. WO/2006/135973. |
2006 Journal Article Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharidesAdams, Y., Freeman, C., Schwartz-Albiez, R., Ferro, V., Parish, C.R. and Andrews, K.T. (2006). Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides. Antimicrobial Agents and Chemotherapy, 50 (8), 2850-2852. doi: 10.1128/AAC.00313-06 |
2006 Journal Article Spectroscopic and structural characterization of products arising from the base-promoted benzylation of 3-sulfoleneBonnet, Muriel, Banwell, Martin G., Willis, Anthony C. and Ferro, Vito (2006). Spectroscopic and structural characterization of products arising from the base-promoted benzylation of 3-sulfolene. Arkivoc, 2006 (x), 35-41. doi: 10.3998/ark.5550190.0007.a05 |
2006 Book Chapter Heparanase as a Target for Anticancer Therapeutics: New Developments and Future ProspectsHammond, E., Bytheway, I. and Ferro, V. (2006). Heparanase as a Target for Anticancer Therapeutics: New Developments and Future Prospects. New Developments in Therapeutic Glycomics. (pp. 251-282) edited by Maryse Delehedde and Hugues Lortat-Jacob. Trivandrum, India: Research Signpost. |
2006 Journal Article Anti-herpes simplex virus activities of two novel disulphated cyclitolsEkblad, M., Bergström, T., Banwell, M. G., Bonnet, M., Renner, J., Ferro, V. and Trybala, E. (2006). Anti-herpes simplex virus activities of two novel disulphated cyclitols. Antiviral Chemistry and Chemotherapy, 17 (2), 97-106. doi: 10.1177/095632020601700205 |
2005 Journal Article Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acidPearson, A.G., Kiefel, M.J.., Ferro, V. and von Itzstein, M. (2005). Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid. Carbohydrate Research, 340 (13), 2077-2085. doi: 10.1016/j.carres.2005.06.029 |
2005 Other Outputs Sulfated oligosaccharide derivativesFerro, Vito, Fairweather, Jon, Karoli, Tomislav and Liu, Ligong (2005). Sulfated oligosaccharide derivatives. WO/2005/085264. |
2005 Other Outputs Glycosaminoglycan (GAG) mimeticsDon, Robert Hugh, Ferro, Vito, Bytheway, Ian, Cochran, Siska, Fairweather, Jon Krueger, Hammond, Edward Timothy, Karoli, Tomislav, Li, Cai Ping and Liu, Ligong (2005). Glycosaminoglycan (GAG) mimetics. WO/2005/061523. |
2005 Journal Article The synthesis and biological evaluation of two analogues of the C-riboside showdomycinRenner, J., Kruszelnicki, I., Adamiak, B., Willis, A.C., Hammond, E., Su, S., Burns, C., Trybala, E., Ferro, V. and Banwell, M.G. (2005). The synthesis and biological evaluation of two analogues of the C-riboside showdomycin. Australian Journal of Chemistry, 58 (2), 86-93. doi: 10.1071/CH04273 |
2005 Conference Publication PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.Gautam, AM, Ferro, V, Wilson, EA, Freeman, C and Parish, C (2005). PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.. AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia Pa, Nov 14-18, 2005. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
2005 Journal Article Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of ProteinsFreeman, Craig, Liu, Ligong, Banwell, Martin G., Brown, Kathryn J., Bezos, Anna, Ferro, Vito and Parish, Christopher R. (2005). Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins. Journal of Biological Chemistry, 280 (10), 8842-8849. doi: 10.1074/jbc.M410769200 |
2005 Journal Article Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88)Karoli, Tomislav, Liu, Ligong, Fairweather, Jon K., Hammond, Edward, Li, Cai Ping, Cochran, Siska, Bergefall, Kicki, Trybala, Edward, Addison, Russell S. and Ferro, Vito (2005). Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). Journal of Medicinal Chemistry, 48 (26), 8229-8236. doi: 10.1021/jm050618p |
2004 Journal Article The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448Fairweather, Jon K., Karoli, Tomislav and Ferro, Vito (2004). The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448. Bioorganic & Medicinal Chemistry, 12 (23), 6063-6075. doi: 10.1016/j.bmc.2004.09.005 |
2004 Journal Article A synthetic heparanase inhibitor reduces proteinuria in passive heymann nephritisLevidiotis, V., Freeman, C., Punler, M., Martinello, P., Creese, B., Ferro, V., van der Vlag, J., Berden, Jo H.M., Parish, C.R. and Power, D.A. (2004). A synthetic heparanase inhibitor reduces proteinuria in passive heymann nephritis. Journal of the American Society of Nephrology, 15 (11), 2882-2892. doi: 10.1097/01.ASN.0000142426.55612.6D |
2004 Journal Article The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammationFerro, V., Hammond, E. and Fairweather, J. K. (2004). The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini Reviews in Medicinal Chemistry, 4 (6), 693-702. doi: 10.2174/1389557043403729 |
2004 Journal Article The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virusNyberg, K., Ekblad, M., Bergström, T., Freeman, C., Parish, C.R., Ferro, V. and Trybal, E. (2004). The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Research, 63 (1), 15-24. doi: 10.1016/j.antiviral.2004.01.001 |
2004 Journal Article Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate librariesLiu, L., Li, C.P., Cochran, S. and Ferro, V. (2004). Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries. Bioorganic & Medicinal Chemistry Letters, 14 (9), 2221-2226. doi: 10.1016/j.bmcl.2004.02.017 |
2004 Journal Article The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448.Fairweather, J.K., Karoli, T. and Ferro, V. (2004). The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448.. Bioorganic & Medicinal Chemistry (12), 6063-6075. |
2003 Journal Article Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonanceCochran, S., Li, C., Fairweather, J.K., Kett, W.C., Coombe, D.R. and Ferro, V. (2003). Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance. Journal of Medicinal Chemistry, 46 (21), 4601-4608. doi: 10.1021/jm030180y |
2003 Journal Article The development of the novel angiogenesis inhibitor PI-88 as an anticancer drugFerro, V. and Don, R. (2003). The development of the novel angiogenesis inhibitor PI-88 as an anticancer drug. Australasian Biotechnology, 13 (1), 38-39. |